Fig. 1
From: Overexpression of endothelin B receptor in glioblastoma: a prognostic marker and therapeutic target?
![Fig. 1](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12885-018-4012-7/MediaObjects/12885_2018_4012_Fig1_HTML.gif)
Endothelin receptor type B (ETBR) mRNA expression and its correlation with GBM patient’s survival as determined by bioinformatics analysis of the TCGA database. a ETBR mRNA expression was significantly higher in patients with GBM (n = 166) than in normal controls (n = 5) as normalized with RSEM (RNA-Seq by Expectation Maximization) software [35] b ETBR expression was higher in patients with untreated GBM than in those with treated GBM. c Survival curves based on clinical information and ETBR mRNA expression of treated and untreated GBM reported in the TCGA database